Assessment of an enhanced program for depression management in primary care: cluster randomised controlled trial

ISRCTN ISRCTN16384353
DOI https://doi.org/10.1186/ISRCTN16384353
Secondary identifying numbers PI060176
Submission date
19/01/2007
Registration date
02/02/2007
Last edited
25/08/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
We put into place a new programme based on the chronic care model to improve the management of depression in primary care and compared its effectiveness with the usual care. The goal of the study was assessed the effectiveness of the new programme in terms of the severity of depression, response to treatment, remission of depression and quality of life related to health. We invite the reader to watch an informative video http://vimeo.com/34126848 and to visit our web page www.projecteindi.cat

Who can participate?
Participants were 338 adult patients, age 18 years or over, from 20 primary care centres of the Catalan Health System in Spain, with diagnostic criteria for major depressive episode according to DSM-IV, who had not taken antidepressants in the last three months and were willing to take antidepressants.

What does the study involve?
Over a period of two years, we recruited 149 patients into the control group (usual care) and 189 in the intervention group (new programme). We compared the effectiveness of the two treatments. The treatment in the new programme involved clinical, educational and organisational procedures including primary care nurses who worked as care-managers. Outcomes were measured at 0, 3, 6 and 12 months.

What are the possible benefits and risks of participating?
The study confirmed that the new programme was more effective than the usual care and showed an improvement of the clinical outcomes of depression in the short (3 and 6 months) and long terms (12 months).

Where is the study run from?
20 primary care centres of the Catalan Health System in the province of Tarragona in Spain.

When is the study starting and how long is it expected to run for?
Recruitment of patients took two years, from June 2007 to June 2009. Results were analysed one year after the recruitment of the last patient in June 2010.

Who is funding the study?
Carlos III Health Institute of the Spanish Ministry of Health and Consumption (Fondo de Investigaciones Sanitarias- Instituto de Salud Carlos III - Ministerio de Sanidad y Consumo) and the Catalan Institute of Health (Institut Català de la Salut), Spain.

Who is the main contact?
Dr Enric Aragonès
earagones.tarte.ics@gencat.cat

Contact information

Dr Enric Aragonès
Scientific

Centre d'Atenció Primària de Constantí
Carrer dels Horts, 6
Constantí
43120
Spain

Phone +34 (0)977 524 109
Email earagones.tarte.ics@gencat.net

Study information

Study designCluster-randomised controlled trial (cluster: primary care medical centres)
Primary study designInterventional
Secondary study designCluster randomised trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleAssessment of an enhanced program for depression management in primary care: cluster randomised controlled trial
Study acronymINDI (INterventions for Depression Improvement)
Study objectivesThe implementation of a structured programme for managing depression will provide better health outcomes for individual patients than usual primary care management.
Ethics approval(s)Research Ethics Committee of the Jordi Gol i Gurina Primary Care Research Institute (IDIAP) Jordi Gol i Gurina, Barcelona, 29/03/2006, ref: P06/16
Health condition(s) or problem(s) studiedModerate to severe, or mild persistent, episode of Major Depression (DSM-IV) who initiate a new antidepressant treatment episode.
InterventionTwo groups, one of which is a control group comprising patients receiving usual primary care management and the other is the intervention group comprising patients on a structured programme for treating depression.

Intervention group:
Implementation of a multicomponent programme for managing depression. It includes training for the general practitioners (eight hours workshop and periodical follow-ups) and availability of evidence-based clinical guidelines based on the National Institute for Health and Clinical Excellence (NICE) depression guideline. It also includes care managers, role developed by staff primary care nurses trained to provide educational and emotional support for the patients, to promote treatment adherence and to provide active and systematic clinical monitoring. The program establishes a minimal number of structured visits: in the acute phase, one week after the incorporation and later monthly up to obtaining the remission; in the continuation phase will be every two months; nevertheless, the plan of follow-up visits will be individualised. The optimal supervision and consultation mechanisms will be implemented with the psychiatric level.

Control group:
Usual primary care management.
Intervention typeOther
Primary outcome measure1. Severity of the depressive symptoms at three, six and 12 months
2. Response rate at three, six and 12 months
3. Remission rate (Patient Health Questionnaire [PHQ-9]) at three, six and 12 months
Secondary outcome measures1. Health-related quality of life (Short Form health survey [SF-12])
2. Satisfaction
3. Medical care conformity with clinical guidelines
4. Adherence to treatment
5. Use of resources
6. Costs
Overall study start date01/01/2007
Completion date31/12/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants396 patients, 20 primary care centres
Key inclusion criteria1. Primary care patients over 18 years of age
2. An episode of major depression (Diagnostic and Statistical Manual of mental disorders - fourth edition [DSM-IV]), moderate to severe, or persistently mild
3. Who need to initiate anti-depressant treatment
Key exclusion criteria1. Limitations that prevent the participation (e.g., severe illness, language limitations, etc)
2. Bipolar disorder
3. Psychotic disorder
4. Dependence of alcohol or drugs
5. Pregnancy or lactation
Date of first enrolment01/06/2007
Date of final enrolment01/06/2009

Locations

Countries of recruitment

  • Spain

Study participating centre

Centre d'Atenció Primària de Constantí
Constantí
43120
Spain

Sponsor information

Jordi Gol i Gurina Primary Care Research Institute (Institut D'Investigació en Atenció Primària) (IDIAP) (Spain)
Government

Fundacio Jordi Gol i Gurina
Gran Via de les Corts Catalanes, 587 àtic
Barcelona
08007
Spain

Phone +34 (0)93 482 41 24
Email jgola@fundaciojgol.org
Website http://www.fundaciojgol.org/
ROR logo "ROR" https://ror.org/0370bpp07

Funders

Funder type

Government

Health Research Fund - Carlos III Health Institute of the Spanish Ministry of Health and Consumption (Fondo de Investigaciones Sanitarias - Instituto de Salud Carlos III-Ministerio de Sanidad y Consumo) (Spain)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 15/12/2012 Yes No